Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[MALT-lymphoma].

D Flieger1, W Fischbach

  • 1Medizinische Klinik, GP-Klinikum Rüsselsheim. d.flieger@gp-ruesselsheim.de

Praxis
|August 17, 2006
PubMed
Summary
This summary is machine-generated.

Gastric MALT lymphoma is often caused by Helicobacter pylori infection, treatable with antibiotics. Further treatment options for refractory cases include radiotherapy, chemotherapy, or surgery, with rituximab showing promise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus-version 4.0.

ESMO gastrointestinal oncology·2026
Same author

Zeitschrift fur Gastroenterologie·2022
Same author

Zeitschrift fur Gastroenterologie·2021
Same author

[Drug-induced gastrointestinal bleeding].

Der Internist·2019
Same author

[Treatment with platelet aggregation inhibitors and additive proton pump inhibitors?]

Der Internist·2018
Same author

[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].

Zeitschrift fur Gastroenterologie·2016
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Area of Science:

  • Gastroenterology and Oncology
  • Immunology

Background:

  • Gastric lymphoma is predominantly extranodal marginal zone-B-cell-lymphoma of mucosa-associated lymphoid tissue (MALT).
  • Helicobacter pylori infection is a newly identified cause of gastric MALT lymphomas.
  • Diagnosis relies on tumor biopsy, with staging utilizing imaging techniques like CT, endosonography, and capsule endoscopy.

Purpose of the Study:

  • To summarize the current understanding and treatment of gastric lymphomas.
  • To highlight the role of Helicobacter pylori in MALT lymphoma development.
  • To discuss therapeutic strategies including antibiotic eradication, conventional treatments, and novel approaches.

Main Methods:

  • Review of diagnostic modalities for gastric lymphoma.
  • Analysis of treatment outcomes for MALT and aggressive gastric lymphomas.

Related Experiment Videos

  • Evaluation of Helicobacter pylori eradication as a primary treatment strategy.

    • Main Results:

    • Antibiotic eradication of Helicobacter pylori offers a breakthrough, side-effect-poor treatment for MALT lymphomas.
    • Refractory MALT lymphomas can be managed with radiotherapy, chemotherapy, or surgical resection.
    • Aggressive gastric lymphomas are primarily treated with chemotherapy and radiotherapy.

    Conclusions:

    • Helicobacter pylori eradication is a key therapeutic advance for gastric MALT lymphoma.
    • Conventional treatments remain options for refractory MALT lymphomas and aggressive lymphomas.
    • Monoclonal antibody therapy, such as rituximab targeting CD20, may improve outcomes in ongoing clinical trials.